Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

ARCTARCT
Showing 8 of 25 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ARCTURUS THERAPEUTICS HLDGS

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 231,628 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $1.6M as of 2026-Q2. The position was increased (+7.0% shares). ARCT represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$1.6M

Current Shares

231,628

Total Value Change

-$3M

Total Shares Change

+34,006

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
231,628
+7.0%
$1.6M0.0%$6.72
27
2026-Q1
Increased
216,500
+17.8%
$1.7M0.0%$7.91
30
2025-Q4
Decreased
183,855
-12.2%
$1.1M0.0%$6.19
0
2025-Q3
Increased
209,456
+10.2%
$3.9M0.0%$18.78
29
2025-Q2
Decreased
190,077
-2.3%
$2.5M0.0%$13.33
0
2025-Q1
Decreased
194,629
-6.3%
$2.1M0.0%$11.58
0
2024-Q4
Increased
207,802
+5.2%
$3.5M0.0%$16.58
28
2024-Q3
Increased
197,622
+1.7%
$4.6M0.0%$22.03
27

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used